Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis

E Capel1, J-F Fléjou, R Hamelin

  • 1INSERM, U762, Paris, France.

Oncogene
|June 5, 2007
PubMed

Insights

Microsatellite instability (MSI) in colorectal cancer is often linked to MLH1 promoter methylation. However, studies using non-specific primer sets may have inaccurately assessed this association.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Approximately 15% of colorectal cancers exhibit microsatellite instability (MSI).
  • In sporadic MSI cases, DNA mismatch repair (MMR) defects are frequently caused by MLH1 promoter methylation.
  • Hereditary MSI cases result from germline mutations in MMR genes.

Purpose of the Study:

  • To investigate the accuracy of MLH1 promoter methylation analysis in relation to MLH1 expression.
  • To evaluate the impact of primer set specificity on detecting MLH1 promoter methylation.
  • To assess the reliability of previous studies on MLH1 methylation and expression correlation.

Main Methods:

  • Methylation-specific PCR was employed to analyze MLH1 promoter methylation.
  • Two primer sets were utilized: one widely used and another specific to a proximal promoter region.
  • A literature review of 161 articles was conducted to examine methodologies used in prior research.

Main Results:

  • A commonly used primer set yielded false positives for MLH1 promoter methylation in samples with intact MMR.
  • A primer set specific for the proximal MLH1 promoter region showed better correlation with MLH1 expression loss.
  • A significant portion (60%) of published studies used non-specific primer sets, potentially leading to inaccurate conclusions.

Conclusions:

  • The choice of primer set is critical for accurate MLH1 promoter methylation analysis.
  • Previous studies using non-specific primers may have overestimated the association between MLH1 methylation and expression loss.
  • Accurate assessment of MLH1 methylation is crucial for understanding sporadic MSI colorectal cancers.